SLC5A2 and liver dysplastic nodule: These observations seem to indicate that renoprotection by SGLT2 inhibitors can be explained by their direct action on SGLT2 in mesangial cells in DN, which means that the effects of SGLT2 inhibitors on DN are independent of tubuloglomerular feedback.